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Disease is not limited to humans. Rather, humans are
but another mammal in a continuum, and as such,
often share similar if not identical diseases with other
mammalian species. Alopecia areata (AA) is such a
disease. Natural disease occurs in humans, nonhuman
primates, many domestic animals, and laboratory
rodents. However, to be useful as models of human
disease, affected animals need to be readily available
to the research community, closely resemble the
human disease, be easy to work with, and provide
reproducible data. To date, the laboratory mouse (most
if not all of the C3H substrains) and the Dundee
experimental bald rat fit these criteria. Manipulations
using full-thickness skin grafts or specific immune cell
transfers have improved the models. New mouse
models that carry a variety of genetic-based immuno-
deficiencies can now be used to recapitulate the
human immune system and allow for human full-
thickness skin grafts onto mice to investigate human-
specific mechanistic and therapeutic questions. These
models are summarized here including where they can
currently be obtained from public access repositories.
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INTRODUCTION
Alopecia areata (AA) is a cell-mediated autoimmune disease
that targets anagen-stage hair follicles in many mammalian
species (Tables 1 and 2) (Sundberg et al., 1995; McElwee and
Hoffmann, 2002) and possibly even feathers in chickens
(Smyth and McNeil, 1999). In humans, this disease has been
subdivided clinically into alopecia areata (patchy hair loss),
alopecia totalis (hair loss on the head), and alopecia
universalis (total body hair loss). Similar forms exist in other
mammals affected with this disease. While reported in a
variety of domesticated species, these are usually single-case
reports that do not make them useful as animal models for
drug efficacy trials (Table 2). However, small groups can be
found through dermatologists at many veterinary colleges and,
as such, may provide additional species for limited drug
efficacy testing before going to human clinical trials.
RODENT MODELS FOR ALOPECIA AREATA
A useful animal model should accurately recapitulate the
human disease, be readily available, and provide reproducible
results. A number of such models have been developed,
primarily in laboratory rodent species, several of which are
commonly used and validated by many different laboratories,
most notably the C3H/HeJ mouse (Sundberg et al., 1994;
McElwee et al., 1998) and Dundee experimental bald rat
(DEBR) (Michie et al., 1991; Oliver et al., 1991). All animal
models provide benefits as well as limitations. Therefore, new
models are constantly being sought to address shortcomings,
but also to determine whether results can be reproduced
before proceeding to human clinical trials.
What are the models of choice and how does one find
them? Table 3 summarizes those that are available and
repositories where the animals can be obtained. Some con-
tract services are available that will perform preclinical
screening for those without such resources.
HUMAN XENOGRAFT MODELS
Human xenografts offer the potential for grafting skin onto
immunodeficient mice and then providing human immune
system cells (Gilhar et al., 2012, 2013). The initial studies
have yet to be reproduced in other laboratories and rigorously
confirmed, partly because few investigators have access to
human tissue and facilities for housing immunodeficient mice.
New combinations of mutations causing immunodeficiency
are being created on genetically selected (congenic or inbred
mouse strains) and pathogen-free stocks, which are already
opening up new directions for xenografts (patient-derived
xenografts for human tumors onto immunodeficient mice).
Those currently heavily used are the NOD.Cg-Prkdcscid
Il2rgtm1Wjl/SzJ (commonly referred to as the NSG mouse)
or NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ (NRG mouse). A
significant advancement in the creation of humanized mice
occurred with the introduction of targeted mutations within
the interleukin (IL) 2 receptor common gamma chain (Il2rg)
gene into inbred strains carrying mutations for specific
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Table 2. Case studies suggesting alternative species for preclinical trials with small numbers
Species Spontaneous References
Dogs Adult onset Tobin et al., 2003; Tobin and Olivry, 2004
Horses Adult onset Colombo et al., 2004; Bruet et al., 2008; Hoolahan et al., 2013; Rosychuk, 2013
Cattle Adult onset Timm et al., 2010; Valentine et al., 2012
Nonhuman primates Adult onset Beardi et al., 2007
Table 1. Animal models with AA or for use with xenografts
Species Spontaneous Graft induced Cell induced Xenograft References
C3H/HeJ1 mouse Adult onset
Wax and wanes
Full-thickness skin
graft, 8–10-week
progressive
See below NA Sundberg et al., 1994;
McElwee et al., 1998; Silva and
Sundberg, 2013
C3H/HeN1 mouse Adult onset NT NT NA McElwee et al., 1999
C3H/HeJ mouse NA NA 8–12 week
progressive
NA Wang et al., 2015
A/J mouse 12–18 months 25þ weeks NA NA McElwee et al., 1999
Prkdcscid, Lystbg NT NT NA Human skin graft plus human
immune cells
Gilhar et al., 2013
NOD/ShiLtSz/J-Prkdcscid,
Il2rgtm1Wtl (NSG)
NT NT NA Human skin graft plus human
immune cells
Predicted, not tested
NOD/ShiLtSz/J-Rag1tm1Mom,
Il2rgtm1Wtl (NRG)
NT NT NA Human skin graft plus human
immune cells
Predicted, not tested
NSG/NRG plus other
mutations
NA Future Future Future Future
DEBR Adult onset
Wax and wanes
NT NT NA Michie et al., 1990;
McElwee, 2004
Abbreviations: AA, alopecia areata; DEBR, Dundee experimental bald rat; NA, not applicable or recipients are not histocompatible with xenografts; NT, not
tested.
1Most if not all C3H substrains react in a similar manner.
Table 3. Sources of animal models for AA research
Animal Source Special order/Contract labs
C3H/HeJ normal (JR# 659) The Jackson Laboratory, Bar Harbor, ME (http://jaxmice.jax.org/) Production strain readily available.
C3H/HeNCrl normal (stain code 025) Charles River Laboratories, Wilmington, MA
(http://www.criver.com/products-services/)
Production strain readily available. No information available on
AA in colony.
C3H/HeNHsd normal (strain code 040) Harland Laboratories (http://www.harlan.com/) Production strain readily available. No information available on
AA in colony.
A/J normal (JR# 646) The Jackson Laboratory, Bar Harbor, ME (http://jaxmice.jax.org/) Production strain readily available.
C3H/HeJ with AA Production strain readily available. Special order for either spontaneous or graft induced AA. The
Jackson Laboratory, In Vivo Services, Sacramento, CA
A/J with AA Production strain readily available. Special order for spontaneous AA.
NOD/ShiLtSz/J-Prkdcscid, Il2rgtm1Wtl (NSG,
JR#5557)
The Jackson Laboratory, Bar Harbor, ME (http://jaxmice.jax.org/) Production strain readily available.
NOD/ShiLtSz/J-Rag1tm1Mom, Il2rgtm1Wtl
(NRG; JR#7799)
The Jackson Laboratory, Bar Harbor, ME (http://jaxmice.jax.org/) Production strain readily available.
DEBR rat Dr HC Hennies, Center for Dermatogenetics, Medizinische
Universita¨t Innsbruck, Innsbruck, Austria (h.hennies@i-
med.ac.at)
Embryos frozen at Charles River Laboratories (quantities very
limited)
Dogs NRA Contact dermatologists at veterinary colleges
Horses NRA Contact dermatologists at veterinary colleges
Cattle NRA Contact dermatologists at veterinary colleges
Nonhuman primates NRA Contact zoos or nonhuman primate centers
Abbreviations: AA, alopecia areata; DEBR, Dundee experimental bald rat; NRA, not readily available.
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immunodeficiencies including Prkdcscid, Rag1tm1Mom, or
Rag2tm1Fwa (Shultz et al., 2007). The Il2RG chain is a critical
component of the IL2, IL4, IL7, IL15, and IL21 high-affinity
ligand-binding receptors (Sugamura et al., 1996; Rochman
et al., 2009). The absence of this gene leads to severe
impairments in T- and B-cell development and function,
completely prevents natural killer (NK) cell development,
and results in multiple other defects in innate immune
function (Cao et al., 1995; Shultz et al., 2005).
Immunodeficient mice bearing a mutated Il2rg gene support
greatly enhanced engraftment of human hematopoietic stem
cells (Shultz et al., 2005), peripheral blood mononuclear cells
(King et al., 2008), and tissues (Stoddart et al., 2011) as
compared with previous models. The base NSG and NRG
mouse strains are continuing to be improved by genetic
manipulation that results in the introduction of targeted
mutations or genes encoding human-specific growth factors
and cytokines. For example, the beige mutation (Lystbg) was
recently added to the NSG mouse model (L. Shultz, personal
communication). Variations of these models in which specific
human HLA genes are added, and the corresponding mouse
H2 alleles removed, provide even more promise to address
very specific immunological questions. These and other
immunodeficient mice will provide novel tools for
unraveling the complexity of the pathogenesis of AA in the
near future.
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